Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, introduce themselves and give an overview of chronic lymphocytic leukemia (CLL), highlighting symptoms and patient presentation.
Antibody Testing May Decrease Infection Risk in Blood Cancer Survivors
More frequent immunoglobulin G testing was associated with a decreased risk of severe infections in patients with CLL and non-Hodgkin lymphoma.
Read More
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
Listen
My Community of Support During Multiple Cancers
My oncologist said that having a supportive community during cancer is just as important as treatment and I could not agree more — it makes me thankful.
The Treatment Journey of a Patient with CLL
In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.
Calquence, Brukinsa Outperform Imbruvica in CLL/SLL Treatment
Patients with chronic lymphocytic leukemia or small lymphocytic lymphoma tended to be more likely to stay on treatment and experience fewer heart toxicities with Calquence or Brukinsa.
Pluvicto May Slow Progression Earlier in Advanced Prostate Cancer
Treatment with Pluvicto following ARPI resulted in favorable progression and response outcomes in PSMA-positive mCRPR.